top of page

New Data Reveals Strong Economic Impact of Texas Biopharmaceutical Industry

For Immediate Release

June 5, 2024

Contact: Lisa Glass 512-695-3569 /

New Data Reveals Strong Economic Impact of Texas Biopharmaceutical Industry

Biopharma footprint in Texas includes more than 300,000 jobs and $95 billion in economic output

AUSTIN, TEXAS – We Work For Health Texas is today sharing new data from vendors across the Lone Star State that shows the important impact the state’s biopharmaceutical industry has on local and national economies.

Vendors play a critical role in equipping America’s biopharmaceutical research companies with the services and supplies they need to propel innovation, ignite research and development, and deliver optimal care for patients. In addition to traditional indicators, such as employment and output, vendors of diverse backgrounds and sizes contribute significantly to the industry’s complete economic footprint.

We Work For Health’s new vendor and supplier expenditure data offers insight into the breadth and depth of the industry’s impact in each state – from those who provide lab equipment and machinery, to contract researchers, to those who handle cleaning, transportation and maintenance services.

“The importance of our vendor and supplier relationships in Texas cannot be overstated,” said Victoria Ford, President and CEO, Texas Healthcare and Bioscience Institute (THBI). “These companies are a crucial component of the ecosystem that continues to provide tens of thousands of good-paying jobs across the state and that helps drive the innovative R&D necessary to deliver the next generation of treatments.”

Key Findings

The data comprises 2022 vendor and supplier information from 15 biopharmaceutical companies in 50 states, the District of Columbia and Puerto Rico, along with jobs and economic impact for the industry as a whole. According to We Work For Health’s analysis, the impact in Texas includes:

  • 2,455 total state vendor relationships and $2.57 billion in total state vendor spending.

  • 49,165 Texas jobs directly supported by the industry and 309,628 total jobs supported overall, which ranks in the top five across all U.S. states.

  • $95 billion in economic output.

“We are passionate about building and delivering complex, sustainable healthcare and R&D construction projects for our customers, and when this passion can be amplified by also helping patients, it’s truly a win-win,” said Jose Rivera, Life Science Regional Leader for DPR Construction. “We are proud to collaborate with and support the biotech and life science sectors in Texas to help bring lifesaving medicines to patients.”

DPR Construction is a self-performing, technical general contractor that specializes in being a trusted partner from procurement to facility delivery. DPR recognizes that the worlds of life sciences research and patient care are increasingly intertwined. And are building more projects with research labs, the capability for small scale manufacturing, and patient care spaces under one roof as the healthcare industry strives to develop new treatments faster and more effectively. DPR also is plugged into Texas’ growing biopharma ecosystem – working with the local economic organizations, specialty supply change managers, educational institutions, and companies themselves to collaborate across a network of resources to cultivate the market in the state.

“Our goal is to provide the professional services that biopharmaceutical sites throughout Texas need to achieve operational excellence by focusing on the 3 Ps – Plant, Process and People,” adds Chas Carabasi, Director of Operations-Southwest for CAI. “It is extremely rewarding to be part of a team that works to improve the quality, readiness and output at these sites so that, hopefully, therapies and cures can be delivered to patients more quickly."

CAI is a team of engineering, quality, and operations experts who exist to accelerate operational readiness and excellence in critical environments. To CAI, operational readiness is more than a short-term goal. Their elite expertise combines top-tier talent with a continuous improvement mindset from the beginning, focusing their approach, processes, and attention to detail to help deliver projects on time and within budget.

We Work For Health Texas supports policies and initiatives that promote employment, innovation, economic growth, and industry competitiveness. The full state-by-state vendor and supplier data – including breakdowns by congressional and state Senate and House districts – can be found at

About We Work For Health

We Work For Health brings together national and local business leaders, and labor, biopharma, patient advocacy and other healthcare-related stakeholders to support policies and initiatives that foster innovation and facilitate the delivery of lifesaving and life-enhancing medicines. As the bedrock of innovative jobs in the U.S. today, the life sciences sector supports more than 4.4 million American employees. Advancing and protecting these jobs is critical for those employees, the economies they support and the patients they serve.

# # #


bottom of page